This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1995:49 Suppl 2:314-6.

doi: 10.2165/00003495-199500492-00083.

Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin

M Fukuda¹, K Sasaki

Affiliations

PMID: 8549346
DOI: 10.2165/00003495-199500492-00083

Comparative Study

Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin

M Fukuda et al. Drugs. 1995.

. 1995:49 Suppl 2:314-6.

doi: 10.2165/00003495-199500492-00083.

Authors

M Fukuda¹, K Sasaki

Affiliation

¹ Department of Ophthalmology, Kanazawa Medical University, Uchinada, Japan.

PMID: 8549346
DOI: 10.2165/00003495-199500492-00083

No abstract available

PubMed Disclaimer

Similar articles

Different iris coloration and uptake of a fluoroquinolone agent into the iris ciliary body of rabbit eyes.
Fukuda M, Sasaki K. Fukuda M, et al. Ophthalmic Res. 1994;26(3):137-40. doi: 10.1159/000267404. Ophthalmic Res. 1994. PMID: 8090430
[The dynamics of melanin-affinitive and non-affinitive antibacterial agents in the iris-ciliary body of rabbit eyes--comparative studies in pigmented and albino rabbits].
Fukuda M, Sasaki K. Fukuda M, et al. Nippon Ganka Gakkai Zasshi. 1992 Oct;96(10):1229-33. Nippon Ganka Gakkai Zasshi. 1992. PMID: 1332455 Japanese.
Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes.
Fukuda M, Sasaki K. Fukuda M, et al. Lens Eye Toxic Res. 1989;6(1-2):339-51. Lens Eye Toxic Res. 1989. PMID: 2488026
A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses.
Wise R, Honeybourne D. Wise R, et al. J Antimicrob Chemother. 1996 May;37 Suppl A:57-63. doi: 10.1093/jac/37.suppl_a.57. J Antimicrob Chemother. 1996. PMID: 8737125 Review.
Clinical pharmacokinetics of sparfloxacin.
Shimada J, Nogita T, Ishibashi Y. Shimada J, et al. Clin Pharmacokinet. 1993 Nov;25(5):358-69. doi: 10.2165/00003088-199325050-00002. Clin Pharmacokinet. 1993. PMID: 8287631 Review.

See all similar articles

Cited by

Corneal UV Protective Effects of a Topical Antioxidant Formulation: A Pilot Study on In Vivo Rabbits.
Palazzo M, Vizzarri F, Ondruška L, Rinaldi M, Pacente L, Guerra G, Merolla F, Caruso C, Costagliola C. Palazzo M, et al. Int J Mol Sci. 2020 Jul 30;21(15):5426. doi: 10.3390/ijms21155426. Int J Mol Sci. 2020. PMID: 32751471 Free PMC article.
Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits.
Bartollino S, Palazzo M, Semeraro F, Parolini B, Caruso C, Merolla F, Guerra G, Costagliola C. Bartollino S, et al. Int Ophthalmol. 2020 Apr;40(4):925-933. doi: 10.1007/s10792-019-01259-6. Epub 2020 Jan 8. Int Ophthalmol. 2020. PMID: 31916063
Comparative dispositions of ofloxacin in human head, axillary, and pubic hairs.
Kosuge K, Uematsu T, Araki SI, Matsuno H, Ohashi K, Nakashima M. Kosuge K, et al. Antimicrob Agents Chemother. 1998 May;42(5):1298-302. doi: 10.1128/AAC.42.5.1298. Antimicrob Agents Chemother. 1998. PMID: 9593174 Free PMC article.
Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.
Nosanchuk JD, Casadevall A. Nosanchuk JD, et al. Antimicrob Agents Chemother. 2006 Nov;50(11):3519-28. doi: 10.1128/AAC.00545-06. Antimicrob Agents Chemother. 2006. PMID: 17065617 Free PMC article. Review. No abstract available.

References

1. Ophthalmic Res. 1990;22(2):123-7 - PubMed
1. Nippon Ganka Gakkai Zasshi. 1988 Nov;92(11):1839-43 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information